Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis (ATOM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by University of Oxford.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Mahidol University
Wellcome Trust
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00579956
First received: December 18, 2007
Last updated: June 3, 2008
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
No publications provided by University of Oxford

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):